Sionna Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sionna Therapeutics, Inc. (SION) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income-61.69-47.26-40.24
Depreciation & Amortization0.670.580.12
Stock Based Compensation3.712.261.69
Change in Working Capital-3.08-0.782.76
Change in Accounts Payable0.470.16-1.51
Change in Other Working Capital-3.54-0.954.28
Other Operating Activities7.602.180.00
Net Cash from Operating Activities-52.79-43.70-36.07
Investing Activities
Capital Expenditures-0.03-1.12-1.87
Purchases of Investments-182.8428.47-40.39
Sales/Maturities of Investments55.9652.0013.00
Net Cash from Investing Activities-126.9127.35-29.26
Financing Activities
Common Stock Issued178.970.030.06
Other Financing Activities0.000.00-0.20
Net Cash from Financing Activities178.970.03110.86
Summary
Net Change in Cash-0.73-16.3245.52
Cash at Beginning of Period39.4855.8010.28
Cash at End of Period38.7539.4855.80
Free Cash Flow-52.81-44.82-37.94